DCGI Archives - Express Pharma

Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer

Navigating the regulatory landscape for nutraceutical startups in India

Indian Immunologicals gets regulatory approval for measles-rubella (MR) vaccine

Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis

Dr Rajeev Raghuvanshi appointed as new DCGI

Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India

DCGI approves MSD India’s Keytruda for treating cervical and esophageal cancers

DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster dose

Tergene Biotech gets CDSCO’s recommendation for PCV15 vaccine

India says samples taken from pharma firm linked to Gambia deaths meet required standards